Special Window for re-lodgement of transfer of shares and updation of KYC by physical shareholders
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has informed BSE about newspaper advertisements published in Financial Express and Lakshadweep on July 25, 2025, regarding a SEBI-mandated special window. This 6-month window, running from July 7, 2025 to January 6, 2026, allows shareholders to re-lodge physical share transfer deeds that were originally submitted before the April 11, 2019 deadline but were returned or not processed due to document deficiencies. The notice also reminds physical shareholders that it is mandatory, per SEBI's November 2021 circular, to furnish PAN, KYC details, and nomination information to the company or its Registrar and Transfer Agent, Bigshare Services Pvt Ltd.
This is a routine regulatory compliance filing with no direct impact on share price or company financials. Shareholders holding physical shares with old, rejected transfer requests now have a fresh opportunity to complete their transfers and update KYC details to avoid future processing issues.